Stockscreener 앱 받기
20.91
5.38%
-1.19
시간 외 거래:
20.92
0.01
+0.05%
전일 마감가:
$22.10
열려 있는:
$21.97
하루 거래량:
2.80M
Relative Volume:
1.97
시가총액:
$1.19B
수익:
$322.02M
순이익/손실:
$-102.47M
주가수익비율:
-11.43
EPS:
-1.8295
순현금흐름:
$-80.57M
1주 성능:
-28.12%
1개월 성능:
-19.95%
6개월 성능:
-38.10%
1년 성능:
-64.57%
1일 변동 폭
$20.67
$22.63
1주일 범위
$20.67
$28.17
52주 변동 폭
$19.35
$62.17
Procept Biorobotics Corp Stock (PRCT) Company Profile
명칭
Procept Biorobotics Corp
전화
(650) 232-9832
주소
150 BAYTECH DRIVE, SAN JOSE
Compare PRCT vs ABT, SYK, MDT, BSX, EW
| 주식 | 가격 | 시가총액 | 매출 | 순이익 | 현금흐름 | 주당 순 이익 |
|---|---|---|---|---|---|---|
PRCT
Procept Biorobotics Corp
|
20.91 | 1.32B | 322.02M | -102.47M | -80.57M | -1.8295 |
ABT
Abbott Laboratories
|
88.50 | 154.45B | 45.13B | 6.28B | 7.38B | 3.5895 |
SYK
Stryker Corp
|
301.14 | 118.05B | 25.27B | 3.34B | 4.57B | 8.6334 |
MDT
Medtronic Plc
|
78.14 | 103.20B | 36.36B | 4.84B | 5.43B | 3.7212 |
BSX
Boston Scientific Corp
|
44.95 | 69.50B | 20.62B | 3.56B | 3.48B | 2.3847 |
EW
Edwards Lifesciences Corp
|
86.68 | 49.68B | 6.30B | 1.07B | 1.09B | 1.8406 |
Procept Biorobotics Corp Stock (PRCT) Upgrades & Downgrades
| 날짜 | 액션 | 분석자 | 등급 변경 |
|---|---|---|---|
| 2026-03-06 | 개시 | Robert W. Baird | Neutral |
| 2026-02-26 | 다운그레이드 | BofA Securities | Neutral → Underperform |
| 2026-02-26 | 다운그레이드 | Oppenheimer | Outperform → Perform |
| 2025-12-12 | 개시 | UBS | Buy |
| 2025-12-08 | 다운그레이드 | BofA Securities | Buy → Neutral |
| 2025-09-02 | 업그레이드 | Oppenheimer | Perform → Outperform |
| 2025-07-09 | 개시 | Stephens | Overweight |
| 2025-07-07 | 개시 | Oppenheimer | Perform |
| 2024-12-02 | 개시 | Morgan Stanley | Overweight |
| 2024-11-14 | 개시 | Jefferies | Hold |
| 2023-08-11 | 개시 | Piper Sandler | Overweight |
| 2023-05-31 | 개시 | William Blair | Outperform |
| 2022-10-31 | 개시 | BTIG Research | Neutral |
| 2022-10-25 | 개시 | Truist | Buy |
| 2022-09-02 | 개시 | Wells Fargo | Overweight |
| 2022-07-15 | 개시 | KeyBanc Capital Markets | Overweight |
| 2022-06-23 | 개시 | B. Riley Securities | Buy |
| 2021-10-11 | 개시 | BofA Securities | Buy |
| 2021-10-11 | 개시 | Cowen | Outperform |
| 2021-10-11 | 개시 | Goldman | Neutral |
| 2021-10-11 | 개시 | Guggenheim | Buy |
| 2021-10-11 | 개시 | SVB Leerink | Outperform |
모두보기
Procept Biorobotics Corp 주식(PRCT)의 최신 뉴스
Why is Procept Biorobotics stock sliding today? By Investing.com - Investing.com South Africa
Why is Procept Biorobotics stock sliding today? - Investing.com
Procept BioRobotics shares slide after Leerink downgrade cites rising competitive risks - MSN
PROCEPT BioRobotics Shares Drop After Downgrade From Leerink Partners - marketscreener.com
This MarketAxess Analyst Is No Longer Bullish; Here Are Top 4 Downgrades For Thursday - Benzinga
Leerink downgrades Procept BioRobotics stock rating on competition - Investing.com UK
Leerink downgrades Procept BioRobotics stock rating on competition By Investing.com - Investing.com Canada
Procept BioRobotics EVP Nouri Alaleh sells $8,116 in stock By Investing.com - Investing.com Australia
Procept BioRobotics EVP Nouri Alaleh sells $8,116 in stock - Investing.com
PROCEPT BioRobotics (PRCT) director receives RSU and option grants as equity pay - Stock Titan
Director Amy Dodrill receives RSUs and options at PROCEPT (NASDAQ: PRCT) - Stock Titan
PROCEPT BioRobotics (PRCT) director Mary Garrett granted RSUs and options - Stock Titan
Director at PROCEPT BioRobotics (PRCT) receives new RSU and option awards - Stock Titan
Director at PROCEPT BioRobotics (PRCT) receives RSU and stock option grants - Stock Titan
Director Frederic Moll of PROCEPT BioRobotics (PRCT) granted RSUs and options - Stock Titan
PROCEPT BioRobotics (PRCT) director receives new RSU and stock option grants - Stock Titan
Director at PROCEPT (PRCT) granted RSUs and stock options - Stock Titan
PROCEPT BioRobotics (NASDAQ: PRCT) reports 2026 shareholder vote outcomes - Stock Titan
[Form 4] PROCEPT BioRobotics Corp Insider Trading Activity - Stock Titan
PRCT (NASDAQ: PRCT) files Form 144 for 285-share sale after vesting - Stock Titan
PRCT (NASDAQ) Rule 144 notice: Director activity, 357 vested shares reported - Stock Titan
PRCT (NASDAQ) insider sale notice — 358 vested shares to be sold - Stock Titan
PROCEPT BioRobotics (PRCT) Is Up 5.7% After New WATER IV Trials Expand Aquablation Testing Scope - simplywall.st
Procept secures FDA IDE for Aquablation and completes WATER IV study enrolment - MSN
Baird initiates Procept BioRobotics stock rating at Neutral - Investing.com
Procept BioRobotics appoints Daniel Puckett to board and audit committee - Investing.com
PROCEPT BioRobotics (PRCT) Is Down 9.2% After Aquablation WATER IV MilestonesWhat's Changed - Yahoo Finance
PROCEPT BioRobotics (PRCT) Is Down 6.0% After WATER IV Trial Milestones – Has The Bull Case Changed? - simplywall.st
Procept Biorobotics wins expanded FDA IDE for Aquablation, completes study enrollment - MassDevice
Siemens Healthineers, AiM team up; Procept completes study enrollment - Yahoo Finance
PROCEPT Biorobotics® Advances Prostate Cancer Program With WATER IV Study Enrollment Completion And Expanded IDE Approval - marketscreener.com
PROCEPT BioRobotics® Advances Prostate Cancer Program with WATER IV Study Enrollment Completion and Expanded IDE Approval - markets.businessinsider.com
Procept BioRobotics completes enrollment in prostate cancer study By Investing.com - Investing.com South Africa
Procept BioRobotics completes enrollment in prostate cancer study - Investing.com
PROCEPT BioRobotics® Advances Prostate Cancer Program with - GlobeNewswire
A Look At PROCEPT BioRobotics (PRCT) Valuation After Its Better Than Expected Q1 Earnings And Analyst Updates - simplywall.st
Here’s What the Street Thinks About PROCEPT BioRobotics Corporation (PRCT) - Insider Monkey
PROCEPT BioRobotics Q1 2026 Earnings: Narrower-Than-Expected Loss Signals ProgressGross Profit Margin - The League of Women Voters of Texas
Lisanti Capital Growth LLC Buys Shares of 35,890 PROCEPT BioRobotics Corporation $PRCT - MarketBeat
DNB Asset Management AS Has $3.13 Million Stock Position in PROCEPT BioRobotics Corporation $PRCT - MarketBeat
Will Stronger AUA Aquablation Guidelines Across Prostate Sizes Change PROCEPT BioRobotics' (PRCT) Narrative? - simplywall.st
AllianceBernstein (PRCT) discloses 147,327 shares; 0.3% stake reported - Stock Titan
PROCEPT BioRobotics Corporation (NASDAQ:PRCT) Receives Average Recommendation of "Hold" from Brokerages - MarketBeat
A Look At PROCEPT BioRobotics (PRCT) Valuation As AUA Guideline Update Expands Aquablation Opportunity - Sahm
Procept Biorobotics Corp (PRCT) 재무 분석
매출
순이익
현금흐름
주당 순 이익
Procept Biorobotics Corp 주식 (PRCT) 내부자 거래
| 내부자 거래 | 관계 | 날짜 | 거래 | 비용 | #주식 | 가치 ($) | #주식 총계 |
|---|---|---|---|---|---|---|---|
| Waters Kevin | EVP, CFO |
Jun 08 '26 |
Sale |
28.48 |
357 |
10,167 |
151,201 |
| Templin Barry L | EVP, Chief Technology Officer |
Jun 08 '26 |
Sale |
28.48 |
358 |
10,195 |
68,953 |
2.43%
자본화:
|
볼륨(24시간):